ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE)-- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and ...
SAN DIEGO, CA—Aviv Regev, PhD, head and executive vice president of Research and Early Development at Genentech, kicked off the Opening Plenary Session at the American Association for Cancer Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results